TY - JOUR
T1 - Serous retinal detachment after panretinal photocoagulation for proliferative diabetic retinopathy
T2 - A case report Tina Dietrich
AU - Schatz, Patrik
AU - Aldayel, Ahmed
AU - Taskintuna, Ibrahim
AU - Abdelkader, Ehab
AU - Mura, Marco
N1 - Publisher Copyright:
© 2017 The Author(s).
PY - 2017/9/19
Y1 - 2017/9/19
N2 - Background: Proliferative diabetic retinopathy is a major cause of visual impairment in working-age adults worldwide. Panretinal photocoagulation is a cornerstone in its management; however, it may include a range of side effects and complications, one of these being serous retinal detachment. To the best of our knowledge, this is the first report of the use of intravitreal injection of bevacizumab for serous retinal detachment after panretinal photocoagulation. Case presentation: A 24-year-old Saudi man with poorly controlled type 1 diabetes presented with bilateral progressive proliferative retinopathy in spite of several sessions of panretinal photocoagulation. After one additional such session, he developed bilateral serous retinal detachment and vision loss, which was managed with a single bilateral intravitreal bevacizumab injection. The serous retinal detachment subsided with partial recovery of vision. Conclusions: Serous retinal detachment after panretinal photocoagulation for proliferative diabetic retinopathy is a rare complication nowadays. In this case, it seems that excessive photocoagulation exceeded the energy-absorbing capacity of the retinal pigment epithelium, leading to a disruption of the blood-retinal barrier. A single injection of bilateral intravitreal bevacizumab was sufficient to control the serous retinal detachment. This effect may have been due to a reduction of vascular leakage resulting from the mechanism of action of this drug. No complications were noted from the injection. Caution should be exerted when attempting bilateral panretinal photocoagulation.
AB - Background: Proliferative diabetic retinopathy is a major cause of visual impairment in working-age adults worldwide. Panretinal photocoagulation is a cornerstone in its management; however, it may include a range of side effects and complications, one of these being serous retinal detachment. To the best of our knowledge, this is the first report of the use of intravitreal injection of bevacizumab for serous retinal detachment after panretinal photocoagulation. Case presentation: A 24-year-old Saudi man with poorly controlled type 1 diabetes presented with bilateral progressive proliferative retinopathy in spite of several sessions of panretinal photocoagulation. After one additional such session, he developed bilateral serous retinal detachment and vision loss, which was managed with a single bilateral intravitreal bevacizumab injection. The serous retinal detachment subsided with partial recovery of vision. Conclusions: Serous retinal detachment after panretinal photocoagulation for proliferative diabetic retinopathy is a rare complication nowadays. In this case, it seems that excessive photocoagulation exceeded the energy-absorbing capacity of the retinal pigment epithelium, leading to a disruption of the blood-retinal barrier. A single injection of bilateral intravitreal bevacizumab was sufficient to control the serous retinal detachment. This effect may have been due to a reduction of vascular leakage resulting from the mechanism of action of this drug. No complications were noted from the injection. Caution should be exerted when attempting bilateral panretinal photocoagulation.
KW - Case report
KW - Optical coherence tomography
KW - Panretinal photocoagulation
KW - Proliferative diabetic retinopathy
KW - Serous retinal detachment
KW - Wide-field imaging
UR - http://www.scopus.com/inward/record.url?scp=85029582654&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029582654&partnerID=8YFLogxK
U2 - 10.1186/s13256-017-1424-y
DO - 10.1186/s13256-017-1424-y
M3 - Article
C2 - 28923115
AN - SCOPUS:85029582654
SN - 1752-1947
VL - 11
JO - Journal of Medical Case Reports
JF - Journal of Medical Case Reports
IS - 1
M1 - 265
ER -